BackAdagio Therapeutics Overview

Adagio Therapeutics Total Liabilities

Track Adagio Therapeutics's total liabilities ($39M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$38.69M
21.98% YoYΔ $-10.90M vs prior year quarter

Peer average

Loading

Adagio Therapeutics Total Liabilities History

Loading

Adagio Therapeutics vs. peers: Total Liabilities Comparison

Loading

Adagio Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Adagio Therapeutics (ADGI) FAQ

As of the most recent data (March 2026), ADGI shows a total liabilities of $39M. That compares with $50M in the prior-year period — down 22.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADGI's total liabilities is now $39M (was $50M) — a 22.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adagio Therapeutics is outperforming or lagging.

Tracking ADGI's total liabilities over time shows whether Adagio Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $39M That compares with $50M in the prior-year period — down 22.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Adagio Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $39M) with ownership activity and broader fundamentals.

Adagio Therapeutics's total liabilities is $39M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.